| UBS (LUX) KEY SELECTION SICAV - EUROPEAN EQUITY VALUE OPPORTUNITY (EUR) U-X-ACC | RVI EUROPA CRECIMIENTO | 25,27% | · | · | 18,95% |
| POLAR CAPITAL BIOTECHNOLOGY R EUR DIS | BIOTECNOLOGÍA | 25,24% | 61,82% | 74,86% | 236,18% |
| TEMPLETON EMERGING MARKETS BOND I (ACC) EUR-H1 | RFI EMERGENTES | 25,23% | 41,82% | 7,70% | 7,04% |
| GOLDMAN SACHS EMERGING MARKETS CORE EQUITY PORTFOLIO OTHER CURRENCY (CLOSE) CHF CAP (LEM CCY VS USD | RVI EMERGENTES | 25,22% | 43,96% | 22,02% | · |
| JPM EUROPE DYNAMIC C (ACC) EUR | RVI EUROPA | 25,22% | 56,67% | 83,45% | 106,93% |
| UBS (LUX) EQUITY SICAV - GLOBAL EMERGING MARKETS OPPORTUNITY (USD) Q-ACC | RVI EMERGENTES | 25,20% | 39,04% | 8,86% | · |
| GOLDMAN SACHS GREATER CHINA EQUITY P CAP EUR | RVI CHINA | 25,19% | 46,40% | 1,80% | 75,72% |
| JPM JAPAN EQUITY I2 (ACC) EUR (HEDGED) | RVI JAPÓN | 25,19% | 117,02% | 82,35% | · |
| UBS (LUX) KEY SELECTION SICAV - EUROPEAN EQUITY VALUE OPPORTUNITY (EUR) I-B-ACC | RVI EUROPA CRECIMIENTO | 25,19% | 62,95% | 122,60% | · |
| POLAR CAPITAL BIOTECHNOLOGY R USD DIS | BIOTECNOLOGÍA | 25,18% | 61,43% | 74,86% | 235,46% |
